Mundipharma extends partnership with NTC for licensing and distribution rights for ophthalmology portfolio into Latin America

Mexico City, 24 July 2018: Mundipharma has expanded its ophthalmology portfolio in Latin America by agreeing a new commercial partnership with NTC – an Italian pharmaceutical company with deep experience in research and development – for exclusive rights to license and distribute a range of ophthalmic medicines across the region. This builds on the …